Artwork
iconShare
 
Manage episode 337211736 series 3380023
Content provided by Stephen Jenkins, MD, Austin Rupp, MD, Stephen Jenkins, MD, and Austin Rupp. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Stephen Jenkins, MD, Austin Rupp, MD, Stephen Jenkins, MD, and Austin Rupp or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Today we have a special guest, Dr. Jared Bunch, an international expert in atrial fibrillation and ablation, to talk about the state of atrial fibrillation and which patients benefit from early catheter ablation based on two new trials published last week in the NEJM. We also talk about whether you should stop ACEi or ARBs in patients admitted with COVID-19, whether oral antibiotics are adequate for uncomplicated appendicitis, and whether you should target a high (90 mmHg) or low (60 mmHg) paO2 in patients with respiratory failure.
STOP-AF First trial
EARLY-AF trial
ACEi and ARBs in COVID-19
IV vs Oral Antibiotics for Appendicitis
Rifaximin after TIPS to Prevent HE
Reimagining Endocarditis Care in an Opioid Epidemic
Lower vs Higher Oxygen Targets
Music from https://filmmusic.io
"Sneaky Snitch" by Kevin MacLeod (https://incompetech.com)
License: CC BY (http://creativecommons.org/licenses/by/4.0/)

Music from Uppbeat (free for Creators!):

https://uppbeat.io/t/soundroll/dope

License code: NP8HLP5WKGKXFW2R

  continue reading

62 episodes